Morpho Inc
TSE:3653
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
776
1 483
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Morpho Inc
EPS (Diluted)
Morpho Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Morpho Inc
TSE:3653
|
EPS (Diluted)
-ÂĄ14
|
CAGR 3-Years
52%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Justsystems Corp
TSE:4686
|
EPS (Diluted)
ÂĄ203
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
|
Obic Business Consultants Co Ltd
TSE:4733
|
EPS (Diluted)
ÂĄ223
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
|
Money Forward Inc
TSE:3994
|
EPS (Diluted)
-ÂĄ108
|
CAGR 3-Years
10%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Sansan Inc
TSE:4443
|
EPS (Diluted)
ÂĄ8
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Rakus Co Ltd
TSE:3923
|
EPS (Diluted)
ÂĄ29
|
CAGR 3-Years
127%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Morpho Inc
Glance View
Morpho, Inc. engages in the research and development, and licensing of image processing technology business. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 151 full-time employees. The company went IPO on 2011-07-21. The firm operates in two segments. The Camera Device segment provides license, development and support products for automobiles, surveillance cameras, business and industrial equipment, centering on smart phones. The Network Service segment provides license, development and support of systems as cloud service providers using image processing technology, image recognition technology, centering on deep learning.
See Also
What is Morpho Inc's EPS (Diluted)?
EPS (Diluted)
-14.8
JPY
Based on the financial report for Oct 31, 2025, Morpho Inc's EPS (Diluted) amounts to -14.8 JPY.
What is Morpho Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
34%
The average annual EPS (Diluted) growth rates for Morpho Inc have been 52% over the past three years , 34% over the past five years .